-
Mercati
-
Azioni
Sustainable finance2025 Euronext ESG Trends ReportLeggi tuttoA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indici
Access the white paperInvesting in the future of Europe with innovative indicesLeggi tuttoThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLeggi tuttoInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondi
-
Obbligazioni
European Defence BondsGroupe BPCE lists the first bondLeggi tuttoFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Prodotti strutturati
-
Derivati
Where European Government Bonds Meet the FutureFixed Income derivativesLeggi tuttoTrade mini bond futures on main European government bonds
-
Commodities
- Panoramica
- Agricultural quotes
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Container Freight Futures
- Consegna e liquidazione
- Specifiche e disposizioni
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLeggi tuttoEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Documenti e risorse
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLeggi tuttoJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 20 Feb 2026 14:30 CET |
ZELLUNA | Zelluna mottar UK MHRA og etisk godkjenning for oppstart av ZIMA-101 første-i-menneske klinisk studie | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 20 Feb 2026 14:30 CET |
ZELLUNA | Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Feb 2026 07:00 CET |
ZELLUNA | Zelluna ASA: Fjerde kvartal 2025 - Viktig regulatorisk milepæl oppnådd med CTA-innlevering | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 12 Feb 2026 07:00 CET |
ZELLUNA | Zelluna ASA: Fourth Quarter 2025 - Key regulatory milestone achieved with CTA Submission | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Feb 2026 08:00 CET |
ZELLUNA | Zelluna inngår avtale med Medpace om første kliniske studie - pasientdata ventes fra medio 2026 | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 11 Feb 2026 08:00 CET |
ZELLUNA | Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial | 20103010 Biotechnology | Non-regulatory press releases |
| 05 Feb 2026 13:30 CET |
ZELLUNA | Zelluna ASA - Grant of Share Options | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Feb 2026 09:30 CET |
ZELLUNA | Zelluna ASA: Invitation to Fourth Quarter 2025 Results Webcast Presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Feb 2026 08:00 CET |
ZELLUNA | Zelluna utnevner Emilie Gauthy til Chief Technology Officer | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 03 Feb 2026 08:00 CET |
ZELLUNA | Zelluna promotes Emilie Gauthy to Chief Technology Officer | 20103010 Biotechnology | Non-regulatory press releases |
| 15 Jan 2026 12:22 CET |
ZELLUNA | Zelluna ASA: Approval and publication of prospectus | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Dec 2025 17:26 CET |
ZELLUNA | Zelluna har nådd en viktig milepæl og innleverer søknad om klinisk studie i Storbritannia for første studie på mennesker av ZI-MA4-1 (ZIMA-101), verdens første MAGE-A4-rettede TCR-NK celleterapi for solide kreftformer. | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 17 Dec 2025 17:26 CET |
ZELLUNA | Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World's First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Dec 2025 12:36 CET |
ZELLUNA | Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World's First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours | 20103010 Biotechnology | Non-regulatory press releases |
| 12 Dec 2025 13:02 CET |
ZELLUNA | Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Dec 2025 09:36 CET |
ZELLUNA | Zelluna ASA: Cancellation of subsequent repair offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Dec 2025 08:22 CET |
ZELLUNA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Dec 2025 18:36 CET |
ZELLUNA | Zelluna ASA - Mandatory notification of trade | 20103010 Biotechnology | Major shareholding notifications |
| 08 Dec 2025 13:52 CET |
ZELLUNA | Zelluna ASA: New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2025 07:50 CET |
ZELLUNA | Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Nov 2025 08:35 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 25 Nov 2025 16:05 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 25 Nov 2025 12:09 CET |
ZELLUNA | ZELLUNA ASA: DISCLOSURE OF LARGE SHAREHOLDING | 20103010 Biotechnology | Major shareholding notifications |
| 25 Nov 2025 11:32 CET |
ZELLUNA | Zelluna ASA - Extraordinary General Meeting held on November 25, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Nov 2025 10:33 CET |
ZELLUNA | Zelluna ASA: New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 13:04 CET |
ZELLUNA | Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 09:10 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Nov 2025 08:28 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Nov 2025 07:29 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Nov 2025 07:00 CET |
ZELLUNA | Zelluna ASA - Ex. date | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 00:58 CET |
ZELLUNA | Zelluna ASA - Key information relating to subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 00:35 CET |
ZELLUNA | Zelluna ASA - Mandatory notification of trade | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 23:52 CET |
ZELLUNA | Zelluna ASA - Successful private placement and retail offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 16:47 CET |
ZELLUNA | Zelluna ASA - Contemplates private placement | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 16:39 CET |
ZELLUNA | Zelluna ASA Reports Third Quarter 2025 Financial Results and Provides General Business Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Oct 2025 07:58 CEST |
ZELLUNA | Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK | 20103010 Biotechnology | Inside information |
| 10 Sep 2025 08:00 CEST |
ZELLUNA | Zelluna Announces Investor Forum on Science & Strategy to be held on Wednesday 17 September 2025 | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Aug 2025 07:00 CEST |
ZELLUNA | Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 14 Aug 2025 12:00 CEST |
ZELLUNA | Zelluna ASA: Invitation to Second Quarter 2025 results webcast presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Jul 2025 12:07 CEST |
ZELLUNA | Zelluna ASA - Grant of Share Options under Long-Term Incentive Program | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Jun 2025 16:19 CEST |
ZELLUNA | Disclosure of share transfer from Inven2 AS | 20103010 Biotechnology | Non-regulatory press releases |
| 27 May 2025 13:51 CEST |
ZELLUNA | Disclosure of Shareholding - Gjelsten Holding AS | 20103010 Biotechnology | Major shareholding notifications |
| 27 May 2025 13:38 CEST |
ZELLUNA | ZLNA - New registered share capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 May 2025 08:37 CEST |
ZELLUNA | ZLNA - Issuance of shares through set-off of option exercise fee | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 May 2025 07:00 CEST |
ZELLUNA | Zelluna ASA Reports First Quarter 2025 Financial Results and Provides General Business Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Apr 2025 08:00 CEST |
ZELLUNA | Zelluna ASA: Invitation to First Quarter 2025 results webcast presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Apr 2025 14:50 CEST |
ZELLUNA | Zelluna ASA - Annual General Meeting held on April 29, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Apr 2025 07:47 CEST |
ZELLUNA | Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours | 20103010 Biotechnology | Inside information |
| 08 Apr 2025 08:43 CEST |
ZELLUNA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Apr 2025 15:21 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |